Apr 23 |
Fusion Pharmaceuticals Inc. (FUSN) Ascends But Remains Behind Market: Some Facts to Note
|
Apr 17 |
Fusion Pharmaceuticals Inc. (FUSN) Stock Moves -0.09%: What You Should Know
|
Apr 11 |
Fusion Pharmaceuticals Inc. (FUSN) Flat As Market Gains: What You Should Know
|
Apr 11 |
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) is definitely on the radar of institutional investors who own 46% of the company
|
Apr 9 |
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
|
Mar 22 |
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
|
Mar 20 |
Fusion Pharmaceuticals GAAP EPS of -$0.39 misses by $0.06
|
Mar 20 |
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
|
Mar 20 |
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
|
Mar 20 |
AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
|